{
    "organizations": [],
    "uuid": "fd3524136e3fe4c41f0d233232aee1366efe9e1b",
    "author": "",
    "url": "https://www.reuters.com/article/brief-ra-pharma-entered-sales-agreement/brief-ra-pharma-entered-sales-agreement-with-stifel-pursuant-to-which-co-may-sell-up-to-50-mln-of-shares-of-common-stock-idUSFWN1SG1N0",
    "ord_in_thread": 0,
    "title": "BRIEF-Ra Pharma - Entered Sales Agreement With Stifel Pursuant To Which Co May Sell, Up To $50 Mln Of Shares Of Common Stock",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9 (Reuters) - Ra Pharmaceuticals Inc:\n* RA PHARMA - ENTERED SALES AGREEMENT WITH STIFEL PURSUANT TO WHICH CO MAY SELL, UP TO $50 MILLION OF SHARES OF COMMON STOCK, THROUGH STIFEL AS SALES AGENT Source text: ( bit.ly/2G0vejI ) Further company coverage:\n ",
    "published": "2018-05-10T00:49:00.000+03:00",
    "crawled": "2018-05-10T01:04:47.049+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "ra",
        "pharmaceutical",
        "inc",
        "ra",
        "pharma",
        "entered",
        "sale",
        "agreement",
        "stifel",
        "pursuant",
        "co",
        "may",
        "sell",
        "million",
        "share",
        "common",
        "stock",
        "stifel",
        "sale",
        "agent",
        "source",
        "text",
        "company",
        "coverage"
    ]
}